The table below summarizes the most recent Dyne Therapeutics insider buying information, with links below the price to see the CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more information about why Dyne Therapeutics insider buys are important for investors to follow.

Date	Insider	Price	Amount
1-9-2024 Insider Buy	Dirk Kersten	$17.50 CAGR »	$29,999,987.50 1,714,285 shares
12-12-2022 Insider Buy	Jason P. Rhodes Director	$10.70 CAGR »	$10,000,016.70 934,581 shares
12-12-2022 Insider Buy	Atlas Venture Opportunity Fund II, L.P. >10% Owner	$10.70 CAGR »	$10,000,016.70 934,581 shares
9-21-2020 Insider Buy	RA CAPITAL MANAGEMENT, L.P. >10% Owner	$19.00 CAGR »	$12,540,000.00 660,000 shares
9-21-2020 Insider Buy	Global Management LP Logos >10% Owner	$19.00 CAGR »	$13,300,000.00 700,000 shares
9-21-2020 Insider Buy	VV Manager II, LLC >10% Owner	$19.00 CAGR »	$15,485,000.00 815,000 shares
3-24-2017 Insider Buy	Robert C. Flexon President and CEO	$7.16 CAGR »	$107,400.00 15,000 shares
3-9-2017 Insider Buy	Robert C. Flexon President and CEO	$7.62 CAGR »	$190,500.00 25,000 shares
11-4-2016 Insider Buy	Robert C. Flexon President and CEO	$8.21 CAGR »	$102,678.75 12,500 shares
3-1-2016 Insider Buy	Robert C. Flexon President and CEO	$10.08 CAGR »	$100,800.00 10,000 shares
12-8-2015 Insider Buy	Patrick Wood III Director	$11.61 CAGR »	$74,304.00 6,400 shares
11-13-2015 Insider Buy	Robert C. Flexon President and CEO	$16.70 CAGR »	$167,000.00 10,000 shares
11-10-2015 Insider Buy	Daniel P. Thompson EVP	$17.55 CAGR »	$17,550.00 1,000 shares
8-21-2015 Insider Buy	Jeffrey Scott Stein Director	$24.71 CAGR »	$24,710.00 1,000 shares
8-20-2015 Insider Buy	Sheree M. Petrone Executive Vice President	$25.78 CAGR »	$77,340.00 3,000 shares
8-20-2015 Insider Buy	Hilary E. Ackermann Director	$26.17 CAGR »	$26,170.00 1,000 shares
8-21-2015 Insider Buy	Martin W. Daley Executive Vice President	$24.71 CAGR »	$49,420.00 2,000 shares
8-18-2015 Insider Buy	Henry D. Jones EVP & Chief Commercial Officer	$25.90 CAGR »	$77,700.00 3,000 shares
8-18-2015 Insider Buy	Carolyn Jeanne Burke EVP	$25.66 CAGR »	$76,980.00 3,000 shares
8-17-2015 Insider Buy	Julius Cox EVP - CAO	$25.42 CAGR »	$24,911.00 980 shares
8-14-2015 Insider Buy	Mario E. Alonso EVP-Strategic Planning & Dev	$25.00 CAGR »	$50,000.00 2,000 shares
8-12-2015 Insider Buy	Robert C. Flexon President and CEO	$22.91 CAGR »	$183,280.00 8,000 shares
8-13-2015 Insider Buy	Clint Freeland Exec. VP and CFO	$24.50 CAGR »	$49,000.00 2,000 shares
8-13-2015 Insider Buy	Catherine B. Callaway Exec VP and General Counsel	$24.38 CAGR »	$60,950.00 2,500 shares
8-11-2015 Insider Buy	John R. Sult Director	$23.61 CAGR »	$249,085.50 10,550 shares
8-12-2015 Insider Buy	Patrick Wood III Director	$22.97 CAGR »	$80,395.00 3,500 shares
5-12-2015 Insider Buy	Robert C. Flexon President and CEO	$32.48 CAGR »	$649,600.00 20,000 shares
5-12-2015 Insider Buy	Clint Freeland Exec. VP and CFO	$32.30 CAGR »	$104,975.00 3,250 shares
2-27-2015 Insider Buy	Paul M. Barbas Director	$27.91 CAGR »	$100,001.53 3,583 shares
11-9-2012 Insider Buy	Patrick Wood III Director	$18.15 CAGR »	$181,500.00 10,000 shares
7-3-2012 Insider Buy	Management, L.L.C. Litespeed >10% Owner	$0.59 CAGR »	$745,015.58 1,264,251 shares
6-29-2012 Insider Buy	Management, L.L.C. Litespeed >10% Owner	$0.58 CAGR »	$540,778.63 932,555 shares
6-27-2012 Insider Buy	Management, L.L.C. Litespeed >10% Owner	$0.57 CAGR »	$366,119.45 636,982 shares
6-11-2012 Insider Buy	Management, L.L.C. Litespeed >10% Owner	$0.46 CAGR »	$6,094,013.28 13,145,674 shares
4-1-2011 Insider Buy	Thomas W. Elward Director	$5.71 CAGR »	$28,567.00 5,000 shares

Also See: Institutional Holders of DYN
Also See: SEC filings

Below we present the annualized performance delivered by Dyne Therapeutics stock since 1-9-2024 (the date of the most recent insider purchase). The performance of the investment from the time Dyne Therapeutics insider buying occurred is the ultimate test of whether insiders were right about DYN being a good buy.

Growth of $10,000.00 Without Dividends Reinvested
Start date:	01/10/2024
End date:	04/29/2024
Start price/share:	$17.34
End price/share:	$25.46
Dividends collected/share:	$0.00
Total return:	46.83%
Annualized Gain:	156.81%
Starting investment:	$10,000.00
Ending investment:	$14,683.00
Years:	0.30

Dyne Therapeutics Insider Buying

This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent Dyne Therapeutics insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).

Also See: Funds Holding DYN

DYN — Current Quote

Quotes delayed 20 minutes

Free DYN Email Alerts:
Get Dividend Alerts

Get SEC Filing Alerts

DYN — Performance

More Insider Buying

Other companies seeing insider buying close in time to when the Dyne Therapeutics Insider Buying occurred are:

Avid Bioservices Insider Buying
American Strategic Investment Insider Buying
Solid Biosciences Insider Buying
Vertex Energy Insider Buying
Hubbell Insider Buying
Aehr Test Systems Insider Buying
Graco Insider Buying
Immunome Insider Buying
Red Violet Insider Buying
Champions Oncology Insider Buying

Dyne Therapeutics Insider Buying

Dyne Therapeutics Insider Buying | www.HoldingsChannel.com